Results 171 to 180 of about 83,207 (290)
Predictive Factor to Castrate-Resistant Prostate Cancer (CRPC) after Primary Androgen Deprivation Therapy (ADT): Single Center Experience in Indonesia
, 2020 Taufiq Nur Budaya, Shigeo Horie, N Mottet, J Bellmunt, M Bolla, E Briers, M Cumberbatch, M De Santis, N Fossati, T Gross, A Henry, S Joniau, T Lam, K Bell, M Kim, J Lee, C Jeong, Y Arai, T Yoshiki, O Yoshida, H Matzkin, P Eber, B Todd, R Van Der Zwaag, M Soloway, D Newling, L Denis, K Vermeylen, H Scher, S Halabi, I Tannock, M Morris, C Stemberg, M Carducci, M Eisenberger, C Higano, G Bubley, R Dreicer, D Petrylak, P Kantoff, E Basch, W Kelly, W Figg, E Small, T Beer, G Wilding, A Martin, M Hussain, J Miller, F Ahmann, G Drach, S Emerson, M Bottaccini, E Benaim, C Pace, P Lam, C Roehrborn, E Cooper, G Dijkman, R Janknegt, De Reijke, T Debruyne, F, J Morote, E Trilla, S Esquena, J Abascal, J Reventos, A Kiper, O Yigitbasi, A Imamoglu, C Tuygun, C Turan, T Choueiri, W Xie, D' Amico, A Ross, E Hu, J Pomerantz, M Regan, M Taplin, M Kantoff, P Sartor, O Oh, W, C Kwak, S Jeong, M Park, E Lee, S Lee, S Park, J Rim, H Choi, C Kim, S Hong, W Kim, S Lee, J Song, J Yoon, H Sim +99 moreopenalex +1 more sourcePhysiological and behavioural effects of continuous remifentanil‐xylazine administration in donkeys
Equine Veterinary Journal, EarlyView.Abstract Background
Remifentanil and xylazine are used as continuous infusions to facilitate standing surgery in horses. Their use for this purpose has not been reported in donkeys. Objectives
To evaluate the behavioural, sedative, and cardiorespiratory effects of continuous intravenous infusion of remifentanil and xylazine in donkeys. Study Design
Non‐Kássia Fernanda Araújo Damasceno, Andressa Nunes Mouta, Larissa de Sant' Ana Alves, Kathryn Nóbrega Arcoverde, Herbert Reis Aragão, Jerson Marques Cavalcante, Valéria Veras de Paula +6 morewiley +1 more sourceInterprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer. [PDF]
JCO Oncol PractMitchell AP, Salner A, Palyca P, Farooki A, Persaud S, Chakraborty N, Bhamidipati D, Klimchuk M, Dinan MA, Leapman MS, Lipitz-Snyderman A, Hamid A, Ostroff JS, Morris MJ. +13 moreeuropepmc +1 more sourceRB1 inactivation in cutaneous carcinomas
Histopathology, EarlyView.Among skin carcinomas, recurrent RB1 inactivation is observed in Merkel cell carcinoma, in a subset of squamous cell carcinoma with bowenoid morphology, in sebaceous carcinoma and in the recently described Wnt/beta‐catenin rosette‐forming carcinoma.Tiffany Liv, Antoine Touzé, David Schrama, Serge Guyétant, Mahtab Samimi, Michael T Tetzlaff, Benjamin A Wood, Paul W Harms, Thibault Kervarrec +8 morewiley +1 more sourceRecent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer. [PDF]
Pharmaceuticals (Basel)Lancia A, Oderda M, Camilli F, Festa E, Bottero M, Alì E, La Mattina S, Bonzano E, Saddi J, Detti B, Santos Hernandez DA, Ingrosso G. +11 moreeuropepmc +1 more sourceExpert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2
Alan H. Bryce, E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg, Daniel P. Petrylak, Neal D. Shore, Daniel E. Spratt, Scott T. Tagawa, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Thomas Boike, Jérémie Calais, Michael A. Carducci, Brian F. Chapin, Michael S. Cookson, John W. Davis, Tanya B. Dorff, Scott E. Eggener, Felix Y. Feng, Martin Gleave, Celestia S. Higano, Andrei Iagaru, Alicia K. Morgans, Michael J. Morris, Katie S. Murray, Wendy Poage, Matthew B. Rettig, Oliver Sartor, Howard I. Scher, Paul Sieber, Eric J. Small, Sandy Srinivas, Evan Y. Yu, Tian Zhang, Phillip J. Koo +37 moreopenalex +1 more source